-
J. Heart Lung Transplant. · Mar 2021
EditorialCOVID-19 vaccination in our transplant recipients: The time is now.
- Saima Aslam, Daniel R Goldstein, Robin Vos, Andrew E Gelman, Michelle M Kittleson, Cameron Wolfe, and Lara Danziger-Isakov.
- Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego, San Diego, California. Electronic address: saslam@health.ucsd.edu.
- J. Heart Lung Transplant. 2021 Mar 1; 40 (3): 169-171.
AbstractWe are entering 2021 with an expanding and effective COVID-19 vaccine armamentarium. Recent interim results from COVID-19 vaccine trials, including more than 80,000 participants worldwide, demonstrate remarkable efficacy and low rate of serious adverse events. Based on experience with other vaccines in transplant recipients and knowing the risk of severe COVID-19 in this population, we believe that COVID-19 vaccines provide potential benefit with minimal risk. We strongly support and encourage COVID-19 vaccination of our transplant recipients.Copyright © 2021 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..